Stock-based compensation - Stock Option Activity (Details) (USD $)
|
3 Months Ended | 12 Months Ended | 3 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2013
|
Mar. 31, 2013
Tecogen
|
Dec. 31, 2012
Tecogen
|
Mar. 31, 2013
Ilois
|
Mar. 31, 2012
Ilois
|
Dec. 31, 2012
Ilois
|
Mar. 31, 2013
Minimum
Tecogen
|
Dec. 31, 2012
Minimum
Tecogen
|
Mar. 31, 2013
Minimum
Ilois
|
Dec. 31, 2012
Minimum
Ilois
|
Mar. 31, 2013
Maximum
Tecogen
|
Dec. 31, 2012
Maximum
Tecogen
|
Mar. 31, 2013
Maximum
Ilois
|
Dec. 31, 2012
Maximum
Ilois
|
|
Stock Options Outstanding [Roll Forward] | ||||||||||||||
Beginning (shares) | 4,386,000 | 575,000 | ||||||||||||
Granted (shares) | 0 | 0 | ||||||||||||
Exercised (shares) | 0 | 0 | ||||||||||||
Canceled and forfeited (shares) | 0 | 0 | ||||||||||||
Expired (shares) | 0 | 0 | ||||||||||||
Ending (shares) | 4,386,000 | 4,386,000 | 575,000 | |||||||||||
Exercisable (shares) | 3,249,250 | 56,250 | ||||||||||||
Vested and expected to vest (shares) | 4,386,000 | 575,000 | ||||||||||||
Exercise Price Per Share [Abstract] | ||||||||||||||
Exercise Price Per Share, Beginning (per share) | $ 0.03 | $ 0.03 | $ 0.10 | $ 0.10 | $ 0.80 | $ 0.80 | $ 0.50 | $ 0.50 | ||||||
Exercise Price Per Share, Granted (per share) | $ 0 | $ 0.00 | ||||||||||||
Exercise Price Per Share, Exercised (per share) | $ 0 | $ 0 | ||||||||||||
Exercise Price Per Share, Cancelled and forfeited (per share) | $ 0 | $ 0 | ||||||||||||
Exercise Price Per Share, Expired (per share) | $ 0 | $ 0 | ||||||||||||
Exercise Price Per Share, Ending (per share) | $ 0.03 | $ 0.03 | $ 0.10 | $ 0.10 | $ 0.80 | $ 0.80 | $ 0.50 | $ 0.50 | ||||||
Weighted Average Exercise Price [Roll Forward] | ||||||||||||||
Beginning (usd per share) | $ 0.49 | $ 0.29 | ||||||||||||
Granted (usd per share) | $ 0.00 | $ 0.00 | ||||||||||||
Exercised (usd per share) | $ 0 | $ 0 | ||||||||||||
Canceled and forfeited (usd per share) | $ 0.00 | $ 0 | ||||||||||||
Expried (usd per share) | $ 0.00 | $ 0 | ||||||||||||
Ending (usd per share) | $ 0.49 | $ 0.49 | $ 0.29 | |||||||||||
Exercisable (usd per share) | $ 0.43 | $ 0.50 | ||||||||||||
Vested and expected to vest (usd per share) | $ 0.49 | $ 0.29 | ||||||||||||
Weighted Average Remaining Life | 4 years 4 months 27 days | 4 years 7 months 27 days | 7 years 2 months 9 days | 7 years 5 months 9 days | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | ||||||||||||||
Outstanding, Aggregate Intrinsic Value | $ 1,356,400 | $ 1,356,400 | $ 120,000 | $ 120,000 | ||||||||||
Exercisable, Aggregate Intrinsic Value | 1,201,075 | 0 | ||||||||||||
Vested and expected to vest, Aggregate Intrinsic Value | $ 1,356,400 | $ 120,000 |